ISA Holdings follow-up: Bialik as the 2026 financing and execution test
Bialik concentrates almost everything ISA still has to prove in 2026 at the project level: sales pace, sales quality, bank milestone compliance, and the ability to turn NIS 113.7 million of expected gross profit into surpluses that arrive only later. The March financing update reduced the risk, but it made the test more precise, not easier.
Bialik Is the 2026 Proof Test
The main article stopped at the right point: Bond A and the Bialik financing line bought ISA time, but they did not settle the 2026 question on their own. This follow-up isolates Bialik because it is the one project where the same test appears without much noise: can the company sell at a pace and on terms the bank is willing to recognize, keep construction moving without reopening the cost gap, and turn expected profit into surpluses that can actually move upstream.
This is no longer a question of whether the project exists. Bialik is a 354-unit free-market residential project in Kiryat Bialik, built in three stages, with an effective 50% share for ISA. Construction began in the third quarter of 2024, completion is expected in the second quarter of 2028, and marketing is expected to end in the second quarter of 2029. That is exactly why it matters: the project is large enough to shape the 2026 read, but transparent enough to show where the real risk sits.
For Bialik, 2026 is a proof year, not a harvest year. Expected gross profit at the 100% project level already stands at NIS 113.7 million, and ISA's expected share of withdrawable surpluses stands at NIS 123.1 million. But most of that money does not belong to 2026: NIS 93.5 million of gross profit has not yet been recognized, and the expected surplus withdrawals are pushed out to 2028-2029 and remain subject to the bank mechanism. So Bialik is not mainly a story about headline project value. It is a story about how quickly, and under what terms, that value becomes execution, financing and cash that can really be released.
| Metric | Status at year-end 2025 and in March 2026 | Why it matters |
|---|---|---|
| Project scale | 354 units, all in the free market | This is an open-market project, not a subsidized-housing one |
| Cumulative sales | 175 units, 49% marketing rate | Almost half the project is sold, but 179 units are still open |
| 2025 sales pace | 59 units sold in 2025 | The project is selling, but not at a pace that makes the milestone question disappear |
| Construction progress | 33.49% cost-based completion | Execution moved forward, but most of the path is still ahead |
| Unrecognized gross profit | NIS 93.5 million | Most of the economics are still future, not closed |
| ISA share of expected surpluses | NIS 123.1 million | A large number, but still bank-dependent and pushed to 2028-2029 |
| Main open condition | Bank-definition presales of NIS 277.8 million by 31 March 2026 | This is the core 2026 test |
2025 ended with 59 new contracts, split by quarter into 24, 9, 17 and 9 units. There were 5 more contracts after the period end. That helps, but it does not change the core picture: half of the project is still unsold, and the kind of jump that would make financing milestones a closed issue has not shown up yet.
What Looks Closed on Paper Still Has to Clear the Bank
On the marketing table, the picture looks reasonable. By year-end 2025, cumulative signed contracts represented NIS 312.3 million of expected revenue, the marketing rate reached 49%, and the average price per square meter on cumulative signed contracts stayed around NIS 14 thousand. At the same time, cost-based completion stood at 33.49%, so the project looks like a standard case of sales moving ahead of construction, but not by a dramatic margin.
What is more interesting is that the banking language and the accounting language are not the same language. If the reader looks only at the signed-contract table, cumulative sales look sizeable. But in the 12 March 2026 update, the remaining condition for Stage B was still defined as bank-definition presales of NIS 277.8 million by 31 March 2026. That is an important signal. It does not necessarily mean sales are missing. It does mean the bank's test does not overlap one-for-one with the signed-contract headline.
That is where the sharper reading of Bialik begins. The 49% marketing headline does not solve the 2026 question by itself. What will decide whether the project truly moves into the next financing stage is whether those sales also satisfy the bank's own definitions, pace and quality thresholds.
The March Update Reduced Binary Risk, but It Did Not Remove the Test
The March 2026 financing update changed the shape of the risk. The project was divided into three phases: Stage A1 with 132 units, Stage A2 with 26 units, and Stage B with 196 units. The cash credit facility now stands at up to NIS 260.8 million, or NIS 247.3 million until the Stage A2 conditions are met. The Sale Law guarantee framework stands at NIS 233.5 million, and is meant to rise to NIS 616.5 million after the Stage B conditions are met, and then to NIS 633 million after the Stage A2 conditions are met.
This matters because the project no longer looks like a binary "there is financing or there is none" case. The framework exists, and the specific-financing section also shows about NIS 323.6 million of unused headroom. But the framework exists in a conditional, staged form. In other words, the pressure has shifted from the question of whether financing exists to the question of whether the company can actually open it in practice.
In that picture, the live condition is Stage B. The company wrote that all the conditions for Stage B had been met except bank-definition presales of NIS 277.8 million, which it expects to achieve. The Stage A2 condition is a final building permit by 30 April 2026, which the company believes can be extended if needed and, in any case, is not material to the financing in its full form. That point matters. It means the key 2026 bottleneck is no longer the existence of the line itself, but performance against a very specific bank sales test.
The link to the parent layer also became tighter after Bond A. In the post-balance-sheet note, the rights to the pledged share of Bialik surpluses were included in the bond security package. So Bialik is no longer only a future value source. It is also part of the company's credit architecture.
Sales Quality Matters More Here Than the Headline Pace
The company describes a housing market in which 20/80 deals, 10/90 deals and contractor loans have become part of the commercial language over the past two years. It also tries to reassure: as of the balance-sheet date, it says contractor campaigns are not material for the group, partly because buyers go through full bank underwriting and partly because a meaningful share of 2025 buyers came from subsidized-housing projects where financing incentives matter less.
Bialik does not benefit from that umbrella. The project page says explicitly that all 354 units are in the free market. So what works at the group level does not necessarily transfer one-for-one here. In Bialik, sales quality matters more than the sales headline. The project still has to sell 179 units in the open market, in the same environment where the company itself says payment terms across the sector have become more generous in order to preserve competitiveness.
The sensitivity table says the same thing from another angle. Unrecognized gross profit stands at NIS 93.5 million. A 10% drop in selling prices on the unsigned part of the project cuts NIS 36.8 million from that number, while a 10% rise in construction costs cuts NIS 25.1 million. That is not a theoretical footnote. It is a way of saying that the unsold half of the project is more exposed to price quality than the sold half already is.
That is why, if Bialik is read as a financing and execution case study, the 2026 test is not only whether more units are sold. The test is whether they are sold on terms that preserve both the financing path and the project's economics.
NIS 123 Million Is Not 2026 Cash
The most eye-catching number on the surplus page is NIS 123.1 million: ISA's expected share of withdrawable surpluses after the partner's share. But a closer read shows that most of this figure is not fresh profit. According to the note, ISA's expected share includes about NIS 24 million of interest on the equity it provided, NIS 77 million of equity repayment, and only about NIS 22 million as ISA's share of the remaining economic profit.
This is a very important analytical point. Bialik is first a capital-recovery mechanism and only then a source of additional profit. In economic terms, most of what the company presents as expected surplus withdrawals is the path to getting invested capital back, plus interest, not "new cash" that lands in 2026 at the parent layer.
Timing also matters. The expected years for receiving payments from the project, from the surplus account and from advances already received are 2028-2029. On top of that, the right to withdraw surpluses is subject first to full payment of the amounts due to the bank and to the bank's approval. After that, the project company is expected to transfer ISA's share of surpluses to the pledged surplus account for Bond A holders. So even when surpluses arrive, they still enter a defined credit route first, not a free parent-level pocket.
That is exactly why Bialik matters so much for 2026. Not because it is supposed to throw cash this year, but because it has to prove that the path from invested capital, through project finance, through free-market sales, to surplus that can be pledged and then released, actually works.
Conclusion
Bialik no longer looks like an open financing hole. The March 2026 update narrowed the risk, split the project into stages, and expanded both financing and guarantee capacity. But it also sharpened what exactly has to happen for the story to work: bank-definition presales, continued execution without reopening the cost gap, and price discipline in a project where every unit sits in the free market.
For the ISA reader, the implication is fairly sharp: Bialik is the 2026 test not because the cash is near, but because the proof is near. If the Stage B presale condition is closed, if the Stage A2 permit issue is resolved without becoming a financing block, and if sales keep moving without too much price give-up, Bialik can shift from a project that looks valuable on paper to one that also supports the company's financing read in practice. If not, it will remain a project with strong headline numbers but too long a distance between expected profit and cash that can really be pulled upstream.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.